Contact

Our portfolio

Cellagenics

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

  • Institute: University of Amsterdam
Industry: Therapeutics
  • Founding year: 2008
Visit website

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Plantics
Reducing plastic waste and lowering CO2 emissions.
Regenesance
Engineering antibodies to treat neurodegenerative and immune diseases.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
Plantics
Reducing plastic waste and lowering CO2 emissions.
Regenesance
Engineering antibodies to treat neurodegenerative and immune diseases.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
Explore full AAV portfolio
Contact